GERN - Rega marang bathi kanthi panyesuaian wutah geron.com

Geron Corporation (GERN) is a pioneer in developing telomerase inhibitors with a unique drug portfolio. The change in the PEG ratio reflects the valuation dynamics relative to earnings growth, where 0.00 becomes the new value of the indicator. Growth potential is supported by the commercial success of Rytelo and interest from big pharma, while FDA approval and patent protection create a sustainable market moat.

GERN: Rasio rega marang bathi tumrap wutah geron.com 04.07.2022 - 12.11.2026

Rincian analitis perusahaan Geron Corporation (GERN)

- nilai pasar lan prakiraan target analis:

Bagan kurs Geron Corp|GERN - Target konsensus

- statistik kapitalisasi pasar:

Nilai pasar Geron Corp.|GERN - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Akuntansi Saham Geron|GERN - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih geron.com|GERN - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

- informasi bathi lan kelipatan valuasi:

GERN - Bathi resik perusahaan|Penghasilan resik sing dikarepake Geron Corporation|GERN - Rasio rega marang bathi|Prakiraan rega marang bathi Geron Bio|GERN - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Geron Corp.|GERN - Bathi operasional EBITDA|Bathi resik saben saham sajroning taun lumaku Geron|GERN - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan geron.com|GERN - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Geron Corporation

Ringkesan analitik perusahaan:Geron Corp

The PEG ratio compares the P/E ratio with earnings growth rates, allowing investors to determine if they are overpaying for future business expansion. The value 0.00 reflects the fundamental value of Geron Corporation (GERN), where monopoly pricing power for a unique myelodysplastic syndromes therapy should ensure a high growth rate, making the current PEG level a key indicator of the asset's undervaluation.

Perusahaan pesaing

Nanobiotix SA (NBTX) - Rasio rega marang wutah bathi resik|Bicycle Pharma - Pangali rega marang bathi tumrap wutah|CytomX Corp (CTMX) - Rega marang bathi kanthi panyesuaian wutah|CATX: Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah GNLX (Genelux Corporation)|Molecular Partners (MOLN) - Rasio rega marang bathi tumrap wutah|Rasio kapitalisasi marang bathi lan wutah ONCY (Oncolytics Biotech)|Rasio rega marang bathi tumrap wutah Lisata Therapeutics Inc.|Rasio rega marang bathi tumrap wutah MBRX|Pangali PEG GRTX|Pangali PEG mtem.com (MTEM)